Estimating the First 90 of the UNAIDS 90-90-90 Goal: A Review
暂无分享,去创建一个
E. Levitan | A. Rana | Dustin M. Long | M. Sohail | S. Heath | M. Kempf | Jeremiah Rastegar | J. Rastegar
[1] J. Justman,et al. HIV Population Surveys - Bringing Precision to the Global Response. , 2018, The New England journal of medicine.
[2] L. Koenig,et al. Vital Signs: Human Immunodeficiency Virus Testing and Diagnosis Delays — United States , 2017, MMWR. Morbidity and mortality weekly report.
[3] R. Song,et al. Estimated HIV Incidence, Prevalence, and Undiagnosed Infections in US States and Washington, DC, 2010–2014 , 2017, Journal of acquired immune deficiency syndromes.
[4] R. Sahabo,et al. Substantial progress in confronting the HIV epidemic in Swaziland : first evidence of national impact , 2017 .
[5] Ian R White,et al. Analyses of Sensitivity to the Missing-at-Random Assumption Using Multiple Imputation With Delta Adjustment: Application to a Tuberculosis/HIV Prevalence Survey With Incomplete HIV-Status Data , 2017, American journal of epidemiology.
[6] M Chavance,et al. Sensitivity analysis of incomplete longitudinal data departing from the missing at random assumption: Methodology and application in a clinical trial with drop-outs , 2016, Statistical methods in medical research.
[7] Barbara Suligoi,et al. How many people are living with undiagnosed HIV infection? An estimate for Italy, based on surveillance data , 2016, AIDS.
[8] Ard van Sighem,et al. Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data , 2015, Epidemiology.
[9] Ian E. Fellows,et al. A New Method for Estimating the Number of Undiagnosed HIV Infected Based on HIV Testing History, with an Application to Men Who Have Sex with Men in Seattle/King County, WA , 2015, PloS one.
[10] C. Szwarcwald,et al. Brief report: Time from infection with the human immunodeficiency virus to diagnosis, United States. , 2015, Journal of acquired immune deficiency syndromes.
[11] N. Bannert,et al. Improved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter Cohort , 2014, PloS one.
[12] R. Brookmeyer,et al. Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda. , 2013, AIDS research and human retroviruses.
[13] Connie Celum,et al. HIV incidence determination in the United States: a multiassay approach. , 2013, The Journal of infectious diseases.
[14] Anne M Johnson,et al. Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] D. Costagliola,et al. New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: results for France , 2011, AIDS.
[16] Lei Wang,et al. Prevention of HIV-1 infection with early antiretroviral therapy. , 2011, The New England journal of medicine.
[17] David P. Wilson,et al. HIV in hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV. , 2011, AIDS.
[18] Bernard Branson,et al. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes. , 2011, AIDS research and human retroviruses.
[19] Patrick Royston,et al. Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.
[20] J. Kaldor,et al. Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back‐projection approach , 2010, HIV medicine.
[21] Daniel Commenges,et al. A multistate approach for estimating the incidence of human immunodeficiency virus by using HIV and AIDS French surveillance data , 2009, Statistics in medicine.
[22] R. Brookmeyer,et al. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results , 2008, Statistics in medicine.
[23] Lisa M. Lee,et al. Estimation of HIV incidence in the United States. , 2008, JAMA.
[24] A. Kamali,et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa , 2007, AIDS.
[25] Odd O Aalen,et al. Bayesian back‐calculation using a multi‐state model with application to HIV , 2005, Statistics in medicine.
[26] C. Dolea,et al. World Health Organization , 1949, International Organization.
[27] N. Pantazis,et al. Using CD4 Data to Estimate HIV Incidence, Prevalence, and Percent of Undiagnosed Infections in the United States , 2017, Journal of acquired immune deficiency syndromes.
[28] Lena Osterhagen,et al. Multiple Imputation For Nonresponse In Surveys , 2016 .
[29] R. Evans. European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[30] N. Michael,et al. Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.